325
Views
1
CrossRef citations to date
0
Altmetric
Review

Nitroxyl Radical-Containing Nanoparticles for Novel Nanomedicine Against Oxidative Stress Injury

&
Pages 509-518 | Published online: 04 May 2011

Bibliography

  • Singh D , ChopraK: The effect of naringin, a bioflavonoid on ischemia–reperfusion induced renal injury in rat.Pharmacol. Res.50, 187–193 (2004).
  • Jung KH , ChuK, KoSYet al.: Early intravenous infusion of sodium nitrite protects brain against in vivo ischemia–reperfusion injury.Stroke37, 2744–2750 (2006).
  • Reddy MK , LabhasetwarV: Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia–reperfusion injury.FASEB J.23(5), 1384–1395 (2009).
  • Yasukawa K , MiyakawaR, YaoT, TsuneyoshiM, UtsumiH: Non-invasive monitoring of redox status in mice with dextran sodium sulphate-induced colitis.Free Rad. Res.43(5), 505–513 (2009).
  • Doi K , SuzukiY, NakaoA, FujitaT, NoiriE: Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney.Kidney Int.65, 1714–1723 (2004).
  • Mohan IK , KhanM, WiselSet al.: Cardioprotection by HO-4038, a novel verapamil derivative, targeted against ischemia and reperfusion-mediated acute myocardial infarction.Am. J. Physiol. Heart Circ. Physiol.296(1), H140–H151 (2009).
  • Goldstein LB : Acute ischemic stroke treatment in 2007.Circulation116(113), 1504–1514 (2007).
  • Pan J , KonstasAA, BatemanB, OrtolanoGA, Pile-SpellmanJ: Reperfusion injury following cerebral ischemia: pathophysiology, MR imaging, and potential therapies.Neuroradiology49(2), 93–102 (2007).
  • Maier CM , HsiehL, CrandallT, NarasimhanP, ChanPH: Evaluating therapeutic targets for reperfusion related brain hemorrhage.Ann. Neurol.59(6), 929–938 (2006).
  • Cherubini A , RuggieroC, PolidoriMC, MecocciP: Potential markers of oxidative stress in stroke.Free Rad. Biol. Med.39(7), 841–852 (2005).
  • Xing B , ChenH, ZhangMet al.: Ischemic postconditioning inhibits apoptosis after focal cerebral ischemia/reperfusion injury in the rat.Stroke39(8), 2362–2369 (2008).
  • Margaill I , PlotkineM, LerouetD: Antioxidant strategies in the treatment of stroke.Free Rad. Biol. Med.39(4), 429–443 (2005).
  • Samuni A , KrishnaMC, RieszP, FinkelsteinE, RussoA: A novel metal-free low molecular weight superoxide dismutase mimic.J. Biol. Chem.263(34), 17921–17924 (1988).
  • Krishna MC , RussoA, MitchellJB, GoldsteinS, DafniH, SamuniA: Do nitroxide antioxidants act as scavengers of O2 or as SOD mimics?J. Biol. Chem.271(42), 26018–26025 (1996).
  • Mitchell JB , SamuniA, KrishnaMCet al.: Biologically active metal-independent superoxide dismutase mimics.Biochemistry29(11), 2802–2807 (1990).
  • Yoshioka H , TanizawaH, OgataT, KazamaS: A novel spin probe with prolonged life for ESR imaging.Biol. Pharm. Bull.18(11), 1572–1575 (1995).
  • Saito K , KazamaS, TanizawaHet al.: ESR imaging on a solid-tumor-bearing mouse using spin-labeled dextran.Biosci. Biotechnol. Biochem.65(4), 787–794 (2001).
  • Welch WJ , MendoncaM, BlauJet al.: Antihypertensive response to prolonged TEMPOL in the spontaneously hypertensive rat.Kidney Int.68, 179–187 (2005).
  • Patel K , ChenY, DennehyKet al.: Acute antihypertensive action of nitroxides in the spontaneously hypertensive rat.Am. J. Physiol. Regul. Integr. Comp. Physiol.290(1), R37–R43 (2006).
  • Ankel EG , LaiCS, HopwoodLE, ZivkovicZ: Cytotoxicity of commonly used nitroxide radical spin probes.Life Sci.40(5), 495–498 (1987).
  • Wilcox CS , PearlmanA: Chemistry and antihypertensive effects of TEMPOL and other nitroxides.Pharmacol. Rev.60(4), 418–469 (2008).
  • Yoshitomi T , MiyamotoD, NagasakiY: Design of core-shell-type nanoparticles carrying stable radicals in the core.Biomacromolecules10(3), 596–601 (2009).
  • Yoshitomi T , SuzukiR, MamiyaT, MatsuiH, HirayamaA, NagasakiY: pH-Sensitive radical-containing-nanoparticle (RNP) for the L-band-EPR imaging of low pH circumstances.Bioconjugate Chem.20(9), 1792–1798 (2009).
  • Iijima M , NagasakiY, OkadaT, KatoM, KataokaK: Core-polymerized reactive micelles from heterotelechelic amphiphilic block copolymers.Macromolecules32(4), 1140–1146 (1999).
  • Nagasaki Y , OkadaT, ScholzC, IijimaM, KatoM, KataokaK: The reactive polymeric micelle based on an aldehyde-ended poly (ethylene glycol)/poly (lactide) block copolymer.Macromolecules31(5), 1473–1479 (1998).
  • Soule BP , HyodoF, MatsumotoKet al.: The chemistry and biology of nitroxide compounds.Free Rad. Biol. Med.42(11), 1632–1650 (2007).
  • Gariboldi MB , TerniF, RavizzaRet al.: The nitroxide TEMPOL modulates anthracycline resistance in breast cancer cells.Free Rad. Biol. Med.40(8), 1409–1418 (2006).
  • Stefano GD , BusiC, MattioliA, FiumeL: Selective delivery to the liver of antiviral nucleoside analogs coupled to a high molecular mass lactosaminated poly-L-lysine and administered to mice by intramuscular route.Biochem. Pharmacol.49(12), 1769–1775 (1995).
  • Lee AS , GastAP, ButunV, ArmesSP: Characterizing the structure of pH dependent polyelectrolyte block copolymer micelles.Macromolecules32(13), 4302–4310 (1999).
  • Addison T , CayreOJ, BiggsS, ArmesSP, YorkD: Incorporation of block copolymer micelles into multilayer films for use as nanodelivery systems.Langmuir24(23), 13328–13333 (2008).
  • Asayama S , MaruyamaA, ChoC, AkaikeT: Design of comb-type polyamine copolymers for a novel pH-sensitive DNA carrier.Bioconjugate Chem.8(6), 833–838 (1997).
  • Xu P , Van-KirkEA, MurdochWJet al.: Anticancer efficacies of cisplatin-releasing pH-responsive nanoparticles.Biomacromolecules7(3), 829–835 (2006).
  • Jiang X , LuoS, ArmesSP, ShiW, LiuS: UV irradiation-induced shell cross-linked micelles with pH-responsive cores using ABC triblock copolymers.Macromolecules39(18), 5987–5994 (2006).
  • Huh KM , MinHS, LeeSC, LeeHJ, KimS, ParkK: A new hydrotropic block copolymer micelle system for aqueous solubilization of paclitaxel.J. Control. Release126(2), 122–129 (2008).
  • Kato N , YanakaK, HyodoK, HommaK, NagaseS, NoseT: Stable nitroxide TEMPOL ameliorates brain injury by inhibiting lipid peroxidation in a rat model of transient focal cerebral ischemia.Brain Res.979(1–2), 188–193 (2003).
  • Rak R , ChaoDL, PlutaRM, MitchellJB, OldfieldEH, WatsonJC: Neuroprotection by the stable nitroxide TEMPOL during reperfusion in a rat model of transient focal ischemia.J. Neurosurg.92(4), 646–651 (2000).
  • Lapchak PA , ChapmanDF, ZivinJA: Pharmacological effects of the spin trap agents N-t-butyl-phenylnitrone (PBN) and 2,2,6,6-tetramethylpiperidine-N-oxyl (TEMPO) in a rabbit thromboembolic stroke model.Stroke32, 147–153 (2001).
  • McDonald MC , ZacharowskiK, BowesJ, CuzzocreaS, ThiemermabnnC: TEMPOL reduces infarct size in rodent models of regional myocardial ischemia and reperfusion.Free Rad. Biol. Med.27(5–6), 493–503 (1999).
  • Miura Y , UtsumiH, HamadaA: Antioxidant activity of nitroxide radicals in lipid peroxidation of rat liver microsomes.Arch. Biochem. Biophys.300(1), 148–156 (1993).
  • Takechi K , TamuraH, YamaokaK, SakuratH: Pharmacokinetic analysis of free radicals by in vivo BCM (blood circulation monitoring) – ESR method.Free Rad. Res.26(6), 483–496 (1997).
  • Marushima A , SuzukiK, NagasakiYet al.: Newly synthesized radical-containing nanoparticles (RNP) enhance neuroprotection after cerebral ischemia–reperfusion injury.Neurosurgery DOI: 10.1227/NEU.0b013e31820c02d9 (2010) (Epub ahead of print).
  • Haseloff RF , Mertsch >K, Rohde E, Baeger I, Grigorev IA, Blasig IE: Cytotoxicity of spin trapping compounds. FEBS Lett.418(1–2), 73–75 (1997).
  • Ankel EG , LaiCS, HopwoodLE, ZivkovicZ: Cytotoxicity of commonly used nitroxide radical spin probes.Life Sci.40(5), 495–498 (1987).
  • Hahn SM , DeLucaAM, CoffinD, KrishnaMC, MitchellJB: In vivo radioprotection and effects on blood pressure of the stable free radical nitroxides.Int. J. Radiat. Oncol. Biol. Phys.42(4), 839–842 (1998).
  • Hahn SM , SullivanFJ, DeLucaAMet al.: Hemodynamic effect of the nitroxide superoxide dismutase mimics.Free Rad. Biol. Med.27(5–6), 529–535 (1999).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.